Mar 07, 2019 / 09:30PM GMT
Operator
Welcome to Sunesis Pharmaceuticals Fourth Quarter and Year-End 2018 Earnings Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded.
I would now like to turn the conference over to Willie Quinn, Chief Financial Officer and Senior Vice President, Corporate Development. Please go ahead.
William P. Quinn - Sunesis Pharmaceuticals, Inc. - Senior VP of Finance & Corporate Development and CFO
Thank you. Thank you all for joining us. With me today are Dayton Misfeldt, Interim Chief Executive Officer; Judy Fox, Chief Scientific Officer; Par Hyare, Vice President, Global Oncology Operations; and Deepali Suri, Vice President, Clinical Operations.
Dayton will review recent corporate events, and I will provide a brief overview of fourth quarter and year-end 2018 financial results. We will then open the call for questions, for which Judy, Par and Deepali will also be available.
Before we begin, let me remind you that during today's conference call, we will be making forward-looking statements that
Q4 2018 Sunesis Pharmaceuticals Inc Earnings Call Transcript
Mar 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers